A critical review on applications of the Avrami equation beyond materials science

The Johnson-Mehl-Avrami-Kolmogorov (JMAK) formalization, often referred to as the Avrami equation, was originally developed to describe the progress of phase transformations in material systems. Many other transformations in the life, physical and social sciences follow a similar pattern of nucleati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Royal Society interface Jg. 20; H. 203; S. 20230242
Hauptverfasser: Shirzad, Kiana, Viney, Christopher
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England 21.06.2023
Schlagworte:
ISSN:1742-5662, 1742-5662
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The Johnson-Mehl-Avrami-Kolmogorov (JMAK) formalization, often referred to as the Avrami equation, was originally developed to describe the progress of phase transformations in material systems. Many other transformations in the life, physical and social sciences follow a similar pattern of nucleation and growth. The Avrami equation has been applied widely to modelling such phenomena, including COVID-19, regardless of whether they have a formal thermodynamic basis. We present here an analytical overview of such applications of the Avrami equation outside its conventional use, emphasizing examples from the life sciences. We discuss the similarities that at least partially justify the extended application of the model to such cases. We point out the limitations of such adoption; some are inherent to the model itself, and some are associated with the extended contexts. We also propose a reasoned justification for why the model performs well in many of these non-thermodynamic applications, even when some of its fundamental assumptions are not satisfied. In particular, we explore connections between the relatively accessible verbal and mathematical language of everyday nucleation- and growth-based phase transformations, represented by the Avrami equation, and the more challenging language of the classic SIR (susceptible-infected-removed) model in epidemiology.
AbstractList The Johnson-Mehl-Avrami-Kolmogorov (JMAK) formalization, often referred to as the Avrami equation, was originally developed to describe the progress of phase transformations in material systems. Many other transformations in the life, physical and social sciences follow a similar pattern of nucleation and growth. The Avrami equation has been applied widely to modelling such phenomena, including COVID-19, regardless of whether they have a formal thermodynamic basis. We present here an analytical overview of such applications of the Avrami equation outside its conventional use, emphasizing examples from the life sciences. We discuss the similarities that at least partially justify the extended application of the model to such cases. We point out the limitations of such adoption; some are inherent to the model itself, and some are associated with the extended contexts. We also propose a reasoned justification for why the model performs well in many of these non-thermodynamic applications, even when some of its fundamental assumptions are not satisfied. In particular, we explore connections between the relatively accessible verbal and mathematical language of everyday nucleation- and growth-based phase transformations, represented by the Avrami equation, and the more challenging language of the classic SIR (susceptible-infected-removed) model in epidemiology.The Johnson-Mehl-Avrami-Kolmogorov (JMAK) formalization, often referred to as the Avrami equation, was originally developed to describe the progress of phase transformations in material systems. Many other transformations in the life, physical and social sciences follow a similar pattern of nucleation and growth. The Avrami equation has been applied widely to modelling such phenomena, including COVID-19, regardless of whether they have a formal thermodynamic basis. We present here an analytical overview of such applications of the Avrami equation outside its conventional use, emphasizing examples from the life sciences. We discuss the similarities that at least partially justify the extended application of the model to such cases. We point out the limitations of such adoption; some are inherent to the model itself, and some are associated with the extended contexts. We also propose a reasoned justification for why the model performs well in many of these non-thermodynamic applications, even when some of its fundamental assumptions are not satisfied. In particular, we explore connections between the relatively accessible verbal and mathematical language of everyday nucleation- and growth-based phase transformations, represented by the Avrami equation, and the more challenging language of the classic SIR (susceptible-infected-removed) model in epidemiology.
The Johnson-Mehl-Avrami-Kolmogorov (JMAK) formalization, often referred to as the Avrami equation, was originally developed to describe the progress of phase transformations in material systems. Many other transformations in the life, physical and social sciences follow a similar pattern of nucleation and growth. The Avrami equation has been applied widely to modelling such phenomena, including COVID-19, regardless of whether they have a formal thermodynamic basis. We present here an analytical overview of such applications of the Avrami equation outside its conventional use, emphasizing examples from the life sciences. We discuss the similarities that at least partially justify the extended application of the model to such cases. We point out the limitations of such adoption; some are inherent to the model itself, and some are associated with the extended contexts. We also propose a reasoned justification for why the model performs well in many of these non-thermodynamic applications, even when some of its fundamental assumptions are not satisfied. In particular, we explore connections between the relatively accessible verbal and mathematical language of everyday nucleation- and growth-based phase transformations, represented by the Avrami equation, and the more challenging language of the classic SIR (susceptible-infected-removed) model in epidemiology.
Author Shirzad, Kiana
Viney, Christopher
Author_xml – sequence: 1
  givenname: Kiana
  orcidid: 0009-0006-2908-9565
  surname: Shirzad
  fullname: Shirzad, Kiana
  organization: Graduate Program in Materials and Biomaterials Science and Engineering, University of California, Merced, CA 95343, USA
– sequence: 2
  givenname: Christopher
  orcidid: 0009-0008-0660-4362
  surname: Viney
  fullname: Viney, Christopher
  organization: Department of Materials Science and Engineering, University of California, Merced, 95343, CA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37340781$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1LxDAQxYMo7odePUqOXrqmkyZNj8viFyyIoOeSpFOMtGk3aVf2v7fqCp7em8dvhuEtyKnvPBJylbJVygp1G6KrV8CArxhkcELmaZ5BIqSE039-RhYxfjDGcy7EOZlNmrFcpXPysqY2uMFZ3dCAe4eftPNU930zRYPrfKRdTYd3pOt90K2juBt_cmrw0PmKtnrA4HQTabQOvcULclZPI14edUne7u9eN4_J9vnhabPeJlZwOSRc5BXTAEqgscArIYrCSDTKZrwWyhjQRqEGLVPz_WouZKG1BouimrYKWJKb37t96HYjxqFsXbTYNNpjN8YSFCguMwH5hF4f0dG0WJV9cK0Oh_KvBvgCInlhVQ
CitedBy_id crossref_primary_10_1007_s10973_025_14105_y
crossref_primary_10_1016_j_jallcom_2024_178054
crossref_primary_10_1016_j_tca_2024_179897
crossref_primary_10_1038_s41535_024_00652_4
crossref_primary_10_1016_j_polymer_2024_127733
crossref_primary_10_1016_j_polymer_2025_129089
crossref_primary_10_1002_prep_12076
crossref_primary_10_1021_jacs_5c07305
crossref_primary_10_1134_S1061933X24601148
crossref_primary_10_1016_j_polymer_2025_128319
crossref_primary_10_3390_foods13203305
crossref_primary_10_1016_j_jaap_2025_107167
crossref_primary_10_1039_D5TC01746G
crossref_primary_10_1016_j_conbuildmat_2024_138222
crossref_primary_10_3390_ijms25021352
crossref_primary_10_1016_j_fuel_2025_135884
crossref_primary_10_1021_acs_langmuir_5c01726
crossref_primary_10_1088_2515_7639_ad9b4f
crossref_primary_10_1002_app_56089
crossref_primary_10_1016_j_mtla_2024_102146
crossref_primary_10_1021_acsestengg_4c00617
crossref_primary_10_1002_smll_202505895
crossref_primary_10_1080_00084433_2025_2517944
crossref_primary_10_1016_j_molliq_2024_125153
crossref_primary_10_1016_j_jssc_2024_124592
crossref_primary_10_1016_j_apsusc_2024_160272
crossref_primary_10_1016_j_jaap_2025_107053
crossref_primary_10_3390_cryst15040295
crossref_primary_10_1016_j_mtcomm_2025_113547
crossref_primary_10_1098_rsos_241696
crossref_primary_10_1016_j_tca_2025_179950
crossref_primary_10_1557_s43578_024_01502_6
crossref_primary_10_1016_j_jeurceramsoc_2025_117677
crossref_primary_10_1016_j_actamat_2025_121135
crossref_primary_10_1007_s11663_025_03640_6
crossref_primary_10_1016_j_addma_2025_104849
crossref_primary_10_1039_D5PY00243E
crossref_primary_10_1007_s00339_024_08006_4
crossref_primary_10_1016_j_jhazmat_2023_133157
crossref_primary_10_1016_j_supflu_2025_106691
crossref_primary_10_1063_5_0256712
crossref_primary_10_1007_s11356_024_35558_y
crossref_primary_10_1016_j_jcis_2025_138102
crossref_primary_10_1039_D4SC07931K
crossref_primary_10_1016_j_biombioe_2024_107457
crossref_primary_10_1051_matecconf_202540705002
crossref_primary_10_1016_j_polymdegradstab_2025_111497
crossref_primary_10_1021_acs_jpclett_5c01395
crossref_primary_10_1038_s44160_024_00643_0
crossref_primary_10_1021_acs_molpharmaceut_4c01119
crossref_primary_10_3390_ijms25063200
crossref_primary_10_1007_s10553_024_01780_0
crossref_primary_10_1080_07373937_2024_2342966
crossref_primary_10_3390_cryst13121690
crossref_primary_10_1016_j_jtice_2024_105854
crossref_primary_10_1016_j_optlastec_2024_111638
crossref_primary_10_1364_OPTCON_560333
crossref_primary_10_1007_s12633_025_03280_0
crossref_primary_10_1002_smtd_202500865
crossref_primary_10_1021_acs_jpcc_5c01854
crossref_primary_10_3390_ma17174429
crossref_primary_10_1111_jace_20531
crossref_primary_10_3390_fib13050050
crossref_primary_10_1111_jace_19498
crossref_primary_10_1007_s11664_025_12153_6
crossref_primary_10_1016_j_jpcs_2023_111542
crossref_primary_10_1007_s10924_025_03566_9
crossref_primary_10_1016_j_hazadv_2025_100750
crossref_primary_10_1016_j_jobe_2023_107954
crossref_primary_10_1016_j_micromeso_2025_113869
crossref_primary_10_1039_D5GC00581G
crossref_primary_10_1039_D5CE00625B
crossref_primary_10_1371_journal_pone_0306489
crossref_primary_10_1103_qcbd_bbjv
crossref_primary_10_1016_j_jcis_2024_07_146
crossref_primary_10_1016_j_heliyon_2024_e38852
crossref_primary_10_1016_j_seppur_2023_125648
crossref_primary_10_1103_5td9_y6w4
crossref_primary_10_1140_epjb_s10051_025_00927_0
crossref_primary_10_1016_j_conbuildmat_2025_143199
crossref_primary_10_1080_01932691_2024_2342434
crossref_primary_10_1016_j_physa_2025_130882
crossref_primary_10_1016_j_jclepro_2025_145357
crossref_primary_10_1038_s41567_025_02859_z
crossref_primary_10_1021_jacs_5c06066
crossref_primary_10_1002_macp_202500147
crossref_primary_10_1007_s11270_025_08169_7
crossref_primary_10_3390_polym16081177
crossref_primary_10_3390_pr12102257
crossref_primary_10_5650_jos_ess25035
crossref_primary_10_1016_j_jre_2024_06_006
crossref_primary_10_1002_star_70098
crossref_primary_10_1016_j_bej_2024_109550
crossref_primary_10_1016_j_cep_2025_110438
crossref_primary_10_3390_cryst14090748
crossref_primary_10_3390_s24165258
crossref_primary_10_1016_j_actamat_2024_119907
crossref_primary_10_1016_j_mtphys_2024_101388
crossref_primary_10_1016_j_apsusc_2025_164432
crossref_primary_10_3390_polym16212956
crossref_primary_10_3390_met14111230
crossref_primary_10_1002_cphc_202400432
crossref_primary_10_1063_5_0277567
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1098/rsif.2023.0242
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1742-5662
ExternalDocumentID 37340781
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
0R~
18M
29L
2WC
4.4
53G
5GY
5VS
ACGFO
ACQIA
ACRPL
ADBBV
ADDVE
ADNMO
AENEX
AFFVI
AGPVY
AJZGM
ALMA_UNASSIGNED_HOLDINGS
ALMYZ
AOIJS
BAWUL
BGBPD
BTFSW
C1A
CAG
CGR
COF
CS3
CUY
CVF
DIK
DU5
EBS
ECM
EIF
EJD
GX1
H13
HH5
HYE
HZ~
KQ8
MRS
MV1
NPM
NSAHA
O9-
OK1
OP1
P2P
RHF
ROL
RPM
RRY
S70
TR2
V1E
W8F
XSW
7X8
ID FETCH-LOGICAL-c536t-357d0a2285ebc23d5599b6eb8c43f58bb2ab8ea2a61b07817569aaa2ce5d22892
IEDL.DBID 7X8
ISICitedReferencesCount 130
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001012466800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1742-5662
IngestDate Thu Jul 10 19:31:57 EDT 2025
Thu Jan 02 22:52:21 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 203
Keywords COVID-19
epidemiology
phase transformations
SIR (susceptible-infected-removed) model
Avrami equation
nucleation and growth
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c536t-357d0a2285ebc23d5599b6eb8c43f58bb2ab8ea2a61b07817569aaa2ce5d22892
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0009-0006-2908-9565
0009-0008-0660-4362
OpenAccessLink https://doi.org/10.1098/rsif.2023.0242
PMID 37340781
PQID 2828364527
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2828364527
pubmed_primary_37340781
PublicationCentury 2000
PublicationDate 2023-06-21
PublicationDateYYYYMMDD 2023-06-21
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-21
  day: 21
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Journal of the Royal Society interface
PublicationTitleAlternate J R Soc Interface
PublicationYear 2023
SSID ssj0037355
Score 2.674621
SecondaryResourceType review_article
Snippet The Johnson-Mehl-Avrami-Kolmogorov (JMAK) formalization, often referred to as the Avrami equation, was originally developed to describe the progress of phase...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 20230242
SubjectTerms COVID-19 - epidemiology
Humans
Materials Science
Thermodynamics
Title A critical review on applications of the Avrami equation beyond materials science
URI https://www.ncbi.nlm.nih.gov/pubmed/37340781
https://www.proquest.com/docview/2828364527
Volume 20
WOSCitedRecordID wos001012466800002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV09T8MwELWAMrAA5bN8yUgMMIQ2du0kE6oQFQtVkUDqVp0TW-pA0jalv5-7xC0sSEgs2SzF57Pvnc_3HmM3zkWAYUgH2mG62gXcc5AlSeBCE4LBCKgzU4lNRINBPBolQ3_hVvpnlaszsTqosyKlO_I2pQZUMhPRw3QWkGoUVVe9hMYma0iEMvSkKxqtqwgykpXqKYJuTLi0FmvSxriNmTgReAp5T0Hqd3hZhZn-3n9_cJ_teoDJe7VHNNmGzQ9Y02_hkt96num7Q_ba46kXOuB1Bwsvcv6zos0LxxEg8t5yDh8Tbmc1Lzg3VdsLR7Bb-y_3cfSIvfef3h6fA6-wEKRK6kUgVZR1QIhYWZMKmRH9mNHWxGlXOhUbI8DEFgTo0BArUKR0AgAitSrDUYk4Zlt5kdtTxgFMp5uqJFYiI1JBBI6W-l5DB0KqULbY9cpsY_RgKktAbovPcvxtuBY7qW0_ntZUG2NcQio0hmd_GH3OdmhB6R2XCC9Yw-H87SXbTpeLSTm_qlwDv4Phyxej0sMs
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+critical+review+on+applications+of+the+Avrami+equation+beyond+materials+science&rft.jtitle=Journal+of+the+Royal+Society+interface&rft.au=Shirzad%2C+Kiana&rft.au=Viney%2C+Christopher&rft.date=2023-06-21&rft.issn=1742-5662&rft.eissn=1742-5662&rft.volume=20&rft.issue=203&rft.spage=20230242&rft_id=info:doi/10.1098%2Frsif.2023.0242&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1742-5662&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1742-5662&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1742-5662&client=summon